Dalmia Bharat consolidated net profit declines 11.03% in the March 2026 quarter

April 28, 2026 · 3:50 pm IST Source: Business Standard
๐Ÿ“Œ

Key Takeaways

  • Sales rise 3.76% to Rs 4245.00 crore Net profit of Dalmia Bharat declined 11.03% to Rs 387.00 crore in the quarter ended March 2026 as against Rs 435.00 crore during the previous quarter ended March 2025.
  • Sales rose 3.76% to Rs 4245.00 crore in the quarter ended March 2026 as against Rs 4091.00 crore during the previous quarter ended March 2025.
  • For the full year,net profit rose 66.76% to Rs 1139.00 crore in the year ended March 2026 as against Rs 683.00 crore during the previous year ended March 2025.
  • Sales rose 5.89% to Rs 14804.00 crore in the year ended March 2026 as against Rs 13980.00 crore during the previous year ended March 2025.

Full Report

Sales rise 3.76% to Rs 4245.00 crore
Net profit of Dalmia Bharat declined 11.03% to Rs 387.00 crore in the quarter ended March 2026 as against Rs 435.00 crore during the previous quarter ended March 2025. Sales rose 3.76% to Rs 4245.00 crore in the quarter ended March 2026 as against Rs 4091.00 crore during the previous quarter ended March 2025.

For the full year,net profit rose 66.76% to Rs 1139.00 crore in the year ended March 2026 as against Rs 683.00 crore during the previous year ended March 2025. Sales rose 5.89% to Rs 14804.00 crore in the year ended March 2026 as against Rs 13980.00 crore during the previous year ended March 2025.

Originally reported by Business Standard.
๐Ÿ’ก

IPO Cracker Take

This market development has implications for IPO investors tracking upcoming issues. See our IPO calendar and live GMP data for the most recent moves.

โ“

Frequently Asked Questions

Market news feeds into IPO pricing decisions, subscription timing, and listing-day sentiment. Track the broader market daily alongside each active IPO's own fundamentals.

Our IPO calendar shows all upcoming, open, and recently listed issues in one place — with price band, GMP, and subscription data.

We publish daily market and IPO news, live GMP updates, and subscription tracking. Bookmark our News page or follow us on social media for real-time updates.
0 Comments

No comments yet. Be the first to share your opinion!